HIV Citation List: August 2 - August 15, 2013
PubMed citations
1. Design, Synthesis and Evaluation of a Potent Substrate-analog Peptide-inhibitor Identified by Scanning Ala/Phe Chemical Mutagenesis, Mimicking Substrate Co-evolution, against Multidrug-resistant HIV-1 Protease. Yedidi, R.S., J.M. Muhuhi, Z. Liu, K.Z. Bencze, K.M. Koupparis, C.E. O'Connor, I.A. Kovari, M.R. Spaller, and L.C. Kovari. Biochemical and Biophysical Research Communications, 2013. [Epub ahead of print]. PMID[23921229].
[PubMed]. HIV_0802-081513.
2. Targeting of the Purine Biosynthesis Host Cell Pathway Enhances the Activity of Tenofovir against Sensitive and Drug-resistant HIV-1. Heredia, A., C.E. Davis, M.S. Reitz, N.M. Le, M.A. Wainberg, J.S. Foulke, L.X. Wang, and R.R. Redfield. Journal of Infectious Disease, 2013. [Epub ahead of print]. PMID[23922365].
[PubMed]. HIV_0802-081513.
3. Cyclophilin Inhibitors as Antiviral Agents. Peel, M. and A. Scribner. Bioorganic & Medicinal Chemistry Letters, 2013. 23(16): p. 4485-4492. PMID[23849880].
[WOS]. HIV_0802-081513.
4. Structure-Activity Relationship Study of Phenylpyrazole Derivatives as a Novel Class of anti-HIV Agents. Mizuhara, T., T. Kato, A. Hirai, H. Kurihara, Y. Shimada, M. Taniguchi, H. Maeta, H. Togami, K. Shimura, M. Matsuoka, S. Okazaki, T. Takeuchi, H. Ohno, S. Oishi, and N. Fujii. Bioorganic & Medicinal Chemistry Letters, 2013. 23(16): p. 4557-4561. PMID[23845222].
[WOS]. HIV_0802-081513.
ISI Web of Knowledge Citations
5. A Synthetic Bivalent Ligand of CXCR4 Inhibits HIV Infection. Xu, Y., S. Duggineni, S. Espitia, D.D. Richman, J. An, and Z.W. Huang. Biochemical and Biophysical Research Communications, 2013. 435(4): p. 646-650. ISI[000321025800024].
[WOS]. HIV_0802-081513.
6. Stereoselective Synthesis of the Key Intermediates of the HIV Protease Inhibitor Fosamprenavir and Its Diastereomer. Panov, I., P. Drabina, J. Hanusek, and M. Sedlak. Synlett, 2013(10): p. 1280-1282. ISI[000320576300023].
[WOS]. HIV_0802-081513.
7. XLHX-124-50 as a Potent HIV-1 Entry Inhibitor Targeting on HIV-1 gp41 Envelope. Li, L., J.Y. Qiu, J. Yang, J.Q. Chen, X.X. Zhang, and S.W. Liu. Acta Pharmacologica Sinica, 2013. 34: p. 151-152. ISI[000322051500662].
[WOS]. HIV_0802-081513.
8. Interaction of Antiretroviral Medications with Finasteride. Ward, D. Journal of the International AIDS Society, 2012. 15: p. 63-63. ISI[000320654200131].
[WOS]. HIV_0802-081513.
9. Potent Inhibition of HIV Replication by RNA-binding Peptide Mimetics with Unprecedented Specificity. Varani, G. Journal of Biomolecular Structure & Dynamics, 2013. 31: p. 131-131. ISI[000320149400202].
[WOS]. HIV_0802-081513.
10. The Discovery of S/GSK1265744: A Carbamoyl Pyridone HIV-1 Integrase Inhibitor. Taoda, Y., B. Johns, J. Weatherhead, D. Temelkoff, T. Kawasuji, H. Yoshida, T. Taishi, R. Kiyama, M. Fuji, H. Murai, T. Yoshinaga, A. Sato, and T. Fujiwara. Journal of the International AIDS Society, 2012. 15: p. 122-122. ISI[000320654200251].
[WOS]. HIV_0802-081513.
11. Identification of Potent and Orally Bioavailable Nucleotide Competing Reverse Transcriptase Inhibitors: In Vitro and in Vivo Optimization of a Series of Benzofurano[3,2-d]pyrimidin-2-one Derived Inhibitors. Sturino, C.F., Y. Bousquet, C.A. James, P. DeRoy, M. Duplessis, P.J. Edwards, T. Halmos, J. Minville, L. Morency, S. Morin, B. Thavonekham, M. Tremblay, J.M. Duan, M. Ribadeneira, M. Garneau, A. Pelletier, S. Tremblay, L. Lamorte, R. Bethell, M.G. Cordingley, D. Rajotte, and B. Simoneau. Bioorganic & Medicinal Chemistry Letters, 2013. 23(13): p. 3967-3975. ISI[000320702900055].
[WOS]. HIV_0802-081513.
12. Etravirine in Protease Inhibitor-free Antiretroviral Combination Therapies. Schuelter, E., N. Luebke, B. Jensen, M. Zazzi, A. Sonnerborg, T. Lengauer, F. Incardona, R. Camacho, J. Schmit, B. Clotet, R. Kaiser, and A. Pironti. Journal of the International AIDS Society, 2012. 15: p. 155-156. ISI[000320654200324].
[WOS]. HIV_0802-081513.
13. Synthesis and Characterization of New Nickel(II) Chelates with S-Alkyl-salicylaldehyde thiosemicarbazones. Sahin, M. and B. Ulkuseven. Phosphorus Sulfur and Silicon and the Related Elements, 2013. 188(5): p. 545-554. ISI[000320020900003].
[WOS]. HIV_0802-081513.
14. HIV-1 Associated Topoisomerase II Beta Kinase: A Potential Pharmacological Target for Viral Replication. Ponraj, K., M. Prabhakar, R.S. Rathore, A. Bommakanti, and A.K. Kondapi. Current Pharmaceutical Design, 2013. 19(26): p. 4776-4786. ISI[000320706800008].
[WOS]. HIV_0802-081513.
15. Notable Difference in anti-HIV Activity of Integrase Inhibitors as a Consequence of Geometric and Enantiomeric Configurations. Okello, M., S. Mishra, M. Nishonov, and V. Nair. Bioorganic & Medicinal Chemistry Letters, 2013. 23(14): p. 4112-4116. ISI[000320704600022].
[WOS]. HIV_0802-081513.
16. Synthesis of Betulin Derivatives Containing Triazole Fragments. Chi, W.F., L. Jin, F.Y. Piao, and R.B. Han. Chemistry of Natural Compounds, 2013. 49(2): p. 264-267. ISI[000320770600016].
[WOS]. HIV_0802-081513.
17. Discovery of Piperidine-linked Pyridine Analogues as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Chen, X.W., Y.Y. Li, S.F. Ding, J. Balzarini, C. Pannecouque, E. De Clercq, H.Q. Liu, and X.Y. Liu. ChemMedChem, 2013. 8(7): p. 1117-1126. ISI[000320928400008].
[WOS]. HIV_0802-081513.
Patent Citations
18. 2-(tert-Butoxy)-2-(7-methylquinolin-6-yl)acetic acid Derivatives as Antiviral Agents and Their Preparation and Use in the Treatment of AIDS. Babaoglu, K., K.L. Bjornson, P. Hrvatin, E. Lansdon, J.O. Link, H. Liu, R. McFadden, M.L. Mitchell, Y. Qi, P.A. Roethle, and L. Xu. Patent. 2013. 2013-US20151 2013103724: 184pp.
[Patent]. HIV_0802-081513.
19. Lignin Compounds Extracted from Chinese Medicine Magnolia and Their Application Thereof. Chen, W., C. Yang, Y. Guo, H. Zhou, T. Zhang, Y. Tang, H. Ding, J. Li, and J. Feng. Patent. 2013. 2011-10386272 103130620: 11pp.
[Patent]. HIV_0802-081513.
20. Peptide Inhibitors and Therapeutic Uses Thereof. Guo, C. and A.J. Gow. Patent. 2013. 2012-368833 20130184202: 31pp.
[Patent]. HIV_0802-081513.
21. Preparation of Propenoate Derivatives of Betulin Useful for the Treatment of HIV. Han, N., B.A. Johns, and J. Tang. Patent. 2013. 2011-CN2159 2013091144: 106pp.
[Patent]. HIV_0802-081513.
22. Preparation of Betulin Propenoate Derivatives for the Treatment of HIV. Han, N., B.A. Johns, and J. Tang. Patent. 2013. 2012-US69688 2013090683: 105pp.
[Patent]. HIV_0802-081513.
23. HIV Membrane Fusion Inhibitors. Malcolm, B.A., J.W.J. Thuring, C.F.R.N. Buyck, W.B.G. Schepens, M.A.J. Kriek, W.M.M. Schaaper, J.W. Slootstra, and P. Timmerman. Patent. 2013. 2012-EP75956 2013092591: 33pp.
[Patent]. HIV_0802-081513.
24. Application of Stilbene-based Compound for Treating and Preventing AIDS. Rao, Z., C. Yang, J. Li, T. Zhang, J. Feng, Y. Tang, Y. Guo, and W. Chen. Patent. 2013. 2011-10411373 103156827: 10pp.
[Patent]. HIV_0802-081513.
25. Application of Stilbene Glycoside-based Compound for Treating and Preventing AIDS. Rao, Z., C. Yang, J. Li, T. Zhang, J. Feng, Y. Tang, C. Peng, and W. Chen. Patent. 2013. 2011-10409315 103156868: 10pp.
[Patent]. HIV_0802-081513.
26. Application of Cortex Magnoliae officinalis Extract in Preparing Drugs for Preventing and Treating AIDS. Rao, Z., C. Yang, Z. Lou, Y. Guo, H. Zhou, W. Chen, T. Zhang, Y. Tang, J. Li, and J. Feng. Patent. 2013. 2011-10387541 103127040: 11pp.
[Patent]. HIV_0802-081513.
27. Preparation of Indene Compounds as CD4-mimetic Inhibitors of HIV-1 Entry and Methods of Therapeutic Use Thereof. Sodroski, J., J.M. Lalonde, A.B. Smith, III, P.D. Kwong, Y.D. Kwon, D.M. Jones, A.W. Sun, J.R. Courter, T. Soeta, T. Kobayashi, A.M. Princiotto, X. Wu, J.R. Mascola, A. Schon, E. Freire, N. Madani, M. Le-Khac, and W.A. Hendrickson. Patent. 2013. 2012-US69708 2013090696: 135pp.
[Patent]. HIV_0802-081513.
28. Preparation of Condensed Tricyclic Compounds as Inhibitors of HIV-1 Replication. Sturino, C., P. Beaulieu, P. Deroy, M. Duplessis, C. James, J.-E. Lacoste, J. Minville, L. Morency, S. Morin, B. Simoneau, and M. Tremblay. Patent. 2013. 2012-CA50909 2013091096: 154pp.
[Patent]. HIV_0802-081513.